Prehospital Resuscitation Intranasal Cooling Effectiveness Survival Study 2
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1022 participants.
Also called NCT06025123
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 1,022 participants
- Sponsor
- Registry
-
NCT06025123
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Austria, Belgium, Germany, Italy, Norway, Slovenia, Spain, Sweden
- Registry status
- Recruiting
Technical summary
Registry record NCT06025123. Randomized; double masking; primary purpose treatment. Start 2024-03-27 (actual); primary completion 2028-02 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Prehospital Resuscitation Intranasal Cooling Effectiveness Survival Study 2
- Acronym
- PRINCESS2
- Condition
- Out-Of-Hospital Cardiac Arrest
- Condition
- Hypothermia
- Condition
- Ventricular Fibrillation
- Intervention (Device)
- Early transnasal evaporative cooling with the RhinoChill device
- Lead sponsor
- Karolinska Institutet
Record details
- Record id
cardio:ct-nct06025123- Content hash
ed5641cfca3cbc9671349b7f00edd50045ad44e317410dda4ccf2a8cb0d4ab1f